chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dizziness; nausea; headache; chills; tired; fevers all day; everything hurts; she still feels bad and she doesn't know how long it will take for her to not feel bad; This is a spontaneous report received from a contactable consumer or other non hcp. A 29-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) dose number unknown via an unspecified route of administration on 26Jul2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 27Jul2021 the patient experienced dizziness, nausea, headache, chills, tired, fevers all day, everything hurts, she still feels bad, and she doesn't know how long it will take for her to not feel bad. Clinical course was reported as 29-year-old female, received the Pfizer COVID-19 Vaccination 2 days ago. She feels bad with dizziness, nausea, headache, chills, tired, as well as fevers all day yesterday. She also reports everything hurts. She will get others sick due to her symptoms she is experiencing after her vaccination. She starts working on Friday. She asks if she will have to go to work on Friday if she is not feeling well still. She does not want to get others sick. The clinical outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
sore ankles & wrists the day p/vax;rash on ankles & wrists;saw PMD;severe tendonitis & arthritis poss a serum sickness like illness;indurated patchy rash on hands, wrists, ankles-joints very tender & swollen;tx w/pred;
IRREGULAR MENSES, ELEVATED LIVER ENZYMES, DEVELOPMENT OF HEPATIC HEMANGIOMA
PATIENT RECEIVED A DOSE OF PFIZER BIVALENT BOOSTER DOSE WAS PAST BUD, SPOKE TO DAUGHTER AND STATED THAT HER MOM HAS NOT EXPERIENCING ANY ADVERSE EVENTS. PATIENT WILL SCHEDULE FOR HER MOM TO BE RE-VACCINATED.
PT CAME IN FOR LAB/TB SKIN TEST/TDAP. I GAVE THE WRONG VACCINE.  HE WAS GIVEN THE DTAP WHICH SHOULD HAVE ONLE BEEN GIVEN TO A PEDI. I CALLED NP DUE TO NURSE MANAGER BEING OUT AFTER THE PROVIDER WAS NOTIFIED.  I CALLED THE CDC AND THEY SENT ME THE PAPER WORK I WAS NEEDING FOR DOCUMENTATION AND TO SEE IF HE WOULD NEED TO TAKE THE CURRECT SHOT AGAIN IN SO MANY DAYS.  THEY SAID IF HE GOT ALL OF HIS SHOTS WHEN HE WAS LITTLE HE WAS FINE NO NEED TO MONITOR OR DO LABS. THE SHOT THAT WAS GIVEN TO HIM WOULD COUNT AND HE WOULD NOT HAVE TO START OVER.  PT DID NOT HAVE AN ADVERSE REACTION.  I CALLED AND TOLD THE PT THAT THE SHOT HE WAS GIVEN WAS A DIFFERENT ONE AND IT WOULD STILL COUNT FOR WHAT HE WAS NEEDING HE STATED HE UNDERSTOOD.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and unknown gender. On an unknown date, the unspecified number of patients were vaccinated with improperly stored VAQTA (lot # K011304 and expiry date: 28-APR-2017: Lot# L000718 and expiry date: 28-APR-2017; lot# K023019 and expiry date: 28-APR-2017) that was not supported. No adverse effects were reported. No product quality complaint (PQC) was reported for VAQTA. This is one of the several reports from the same reporter. Additional information has been requested.
running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer); not feeling well; not feeling normal; feeling tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD22-024693 (Moderna), 149362 (Moderna).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 16Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "morphine allergy" (unspecified if ongoing), notes: Allergies (medications, food and other products) sulfa and cipro antibiotics and morphine; "cipro antibiotics" (unspecified if ongoing), notes: Allergies (medications, food and other products) sulfa and cipro antibiotics and morphine; "kidney-pancreas transplant patient" (unspecified if ongoing), notes: kidney-pancreas transplant patient; "kidney-pancreas transplant patient" (unspecified if ongoing), notes: kidney-pancreas transplant patient; "Sulfa" (unspecified if ongoing), notes: Allergies (medications, food and other products) sulfa and cipro antibiotics and morphine. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 22Jan2021, for COVID-19 immunization, reaction(s): "not feeling well", "not feeling normal", "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours", "feeling tired"; BNT162b2 (DOSE 2, SINGLE), administration date: 13Feb2021, for COVID-19 immunization, reaction(s): "not feeling well", "not feeling normal", "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer) and only lasted 48 hours", "feeling tired". The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "running a low grade with temperatures below 100°F/fever/she experienced all of them with her previous vaccines (Pfizer)"; MALAISE (non-serious), outcome "unknown", described as "not feeling well"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "not feeling normal"; FATIGUE (non-serious), outcome "unknown", described as "feeling tired". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, malaise, feeling abnormal, fatigue.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200073355 same patient, different vaccine dose/event;US-PFIZER INC-202201194741 same patient, different vaccine dose/event;US-PFIZER INC-202201194743 same patient, different vaccine dose/event;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Apr2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 66 years for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: negative, notes: tested negative; positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. included Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Hypertension-Severe
Information has been received from a physician for the pregnancy registry for GARDASIL concerning a 22 year old female with a history of papanicolaou smear abnormal and cervical dysplasia who on 05-AUG-2008 was vaccinated with a first dose of GARDASIL 0.5 ml IM in her left upper arm. Concomitant therapy included "FOUCACIO". On 02-SEP-2008 the patient went to the office and blood work was drawn. The patient was positive for pregnancy. No adverse event was reported. On 03-SEP-2008 the patient was 2 or 3 weeks gestation. The last menstrual period was approximately 12-AUG-2008. The estimated due date is 19-MAY-2009. Additional information has been received from a Pregnancy Registry memo. The patient underwent an elective termination of pregnancy prior to 20-OCT-2008 for reasons that are not related to the vaccine. Additional information has been requested.
Right after the injection my arm had a large hard spot at the injection. Of course figured it was normal. The spot became really sore to the point of being unable to sleep on that side or touch it. The injection site was very hot and painful. I did get a low grade fever the night of the injection. The spot did not improve over the week so on June 24, I returned to the doctors off and say the PA. At this time the spot was super painful and even my sleeve touching it hurt. The spot looked buried (now believe that was redness). She said the reaction was normal but was going to go ahead give an antibiotic and antihistamine. There was not improvement with that medication and so I got back into the doctor's office on June 28. I at this time saw my family doctor. He measured the site and it was 1.5inches by 1.5 inches. He change the antibiotic and told me to call if it was not better in 5 days. I at this point believe it was a abscess. I waited 4 days since the office was close at 5 days and it was a holiday weekend. By July 2, my arm was much improved the site was smaller. I called the office letting them know believing I needed more antibiotic, doctor prescribed more but advised in not taking it since there was improvement. He did not order the same antibiotic instead he ordered the one I was one prior. The as of today July 7, the site is much improved there is still a very small knot, but is is not painful or red.
On the side of the vaccination administration developed pain in arm - from elbow up in to the neck and also right side of chest. Lymph nodes were enalarged and palpable - extremely painful. Remained enlarge for 10 day. Developed aches and flu like symptoms.
A few minutes after receiving the Fluad Quad 65+ vaccine, the patient had pain in her legs, back, and face. Her face felt flushed and she had a headache. It only lasted about 5-7 minutes and then she felt ok. The patient was monitored for 1 hour and she was given water.
pain; arthritis pain; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was not reported, Expiry date: unknown, at the age of 75 years), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she received first dose of vaccine on an unspecified date and took Aleve days later due to pain she experienced and her arthritis pain. She would like to know the information on if it is okay to take pain relievers before or after vaccination. Therapeutic measures were taken as a result of pain, arthritis pain. The reporter assessed the events as non-serious. The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Shot site became really red with huge line going across his leg. Slight fever, leg is hot, sore to touch, and very swollen. Seems to be in a lot of pain.
26MAY92 recvd 1 dose of Engerix-B & immed exp mild inject site soreness which resolved; 16JUL92 215PM recvd 2nd dose of Engerix-B 17JUL92 w/fever of 99, severe h/a, dizziness, nausea, vomiting & achy joints allover;
Patient stated that she experienced a significant amount of pain during the injection and added that the injection occurred above her deltoid. She continued to experience excruciating pain and some swelling over the next few days and was unable to move her arm the way she is normally able to. She applied ice and that helped with the swelling. Two weeks later she still experiences some pain and she complains of some limitation of range of motion.
Later experienced shortness; Swollen face; Swollen arms; Teeth ache; Burning eyes; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Later experienced shortness), SWELLING FACE (Swollen face), PERIPHERAL SWELLING (Swollen arms), TOOTHACHE (Teeth ache) and EYE IRRITATION (Burning eyes) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced DYSPNOEA (Later experienced shortness), SWELLING FACE (Swollen face), PERIPHERAL SWELLING (Swollen arms), TOOTHACHE (Teeth ache), EYE IRRITATION (Burning eyes) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Later experienced shortness), SWELLING FACE (Swollen face), PERIPHERAL SWELLING (Swollen arms), TOOTHACHE (Teeth ache), EYE IRRITATION (Burning eyes) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not administered. Treatment for the event was not taken.
Strong metallic taste in mouth, day of injection, lasted about 12 hours Severe unbearable pain in hips and lower back, day of injection, lasting 24 hours and then subsiding to uncomfortable pain the following day. Cough, sneezing, sore throat, headache, chills, feeling of being unwell starting on day two after receiving the injection, still feeling this way 24 hours later.
DIED FROM THE VACCINE; This spontaneous report received from a consumer via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient was very healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, after vaccination patient died from unknown cause of death. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0-20210818781-COVID-19 Vaccine AD26.COV2.S-Died From The Vaccine. This event(s) is considered un-assessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
I had fever, loss of appetite. no energy, slept most of the day. On Sunday, I forced my self to get up that's when I passed out. My husband took me to the garage area elevated my legs took the EMS awhile to arrive. The firefighter was called out they got my blood pressure stable. I was not taken to the ER.
all of a sudden felt excessively tired, went to bed early that day; heart was racing so fast possibly due to anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (heart was racing so fast possibly due to anxiety) and FATIGUE (all of a sudden felt excessively tired, went to bed early that day) in an 83-year-old female patient who received mRNA-1273 (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Lacunar stroke (affected their right side.) on 01-Dec-2018. Concomitant products included APIXABAN (ELIQUIS) from 01-Dec-2018 to an unknown date for Lacunar stroke.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. In March 2021, the patient experienced ANXIETY (heart was racing so fast possibly due to anxiety). On 19-Mar-2021, the patient experienced FATIGUE (all of a sudden felt excessively tired, went to bed early that day). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. On 19-Mar-2021, ANXIETY (heart was racing so fast possibly due to anxiety) and FATIGUE (all of a sudden felt excessively tired, went to bed early that day) had resolved.        The action taken with mRNA-1273 (Unknown) was unknown.       This case was linked to MOD-2021-100481, MOD-2021-100481, MOD-2021-101008 (Patient Link).
Supraclavicular lymph node swelled to about pea size after 1st dose; This is a spontaneous report from a contactable Other-HCP. This 48-year-old female Other-HCP reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) at Left arm at single dose for COVID-19 immunization in Dec2020 06:00 AM.  Relevant history included Known- allergies: Augmentin. Other medications in two weeks included sertraline 50mg, vitamin D3 5000 IU. The patient was not pregnant. The patient experienced  supraclavicular lymph node swelled to about pea size after 1st dose and stayed that size until 2nd dose.  The outcome of event was Recovered with lasting effects. No treatment was received. The patient was not diagnosed with covid-prior-vaccination. The patient did not have covid-tested-post-vaccination.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021030973 Same patient same product, similar event, different event time gap
Td given 8/18/03 IM left deltoid. Next day pt developed redness and soreness. Came back to office on 9/10/03 with 2cm x 2cm area of tenderness, erythema over left upper arm. Treated with Celebrex and Omnicef BID for 7 days. Recheck 9/17. Reported area had drained. Less redness and soreness. Much improved.
The Pfizer Bivalent booster was administered before the patient had completed the primary series. The patient presented to the clinic with the intent of completing the Moderna primary series but was given the Pfizer Bivalent booster accidentally.
NEW ONSET 06/04/2021 POST J/J COVID-19 VACCINE ADMINSTRATION. PATIENT WITH C/O BLOOD SHOT EYES, NAUSEA/VOMITING, KIDNEY PAIN, SYNCOPE, FATIGUE, INCONTINENCE, HAIR LOSS, HIVES AROUND INJECTION SITE AND SAME EXTREMITY. PATIENT WENT TO SICK CALL BUT WAS SENT TO FACILITY ASSIGNED TO WITH LIMITED SICK CALL. NO AFFECTS NOW. INITIAL SYPMTOMS LAST A FEW WEEKS AFTER ADMINISTRATION.
Ride side rib pain. Got worse for a day or two, couldn't bend over, get off couch without assistance, uncomfortable to sit, sleep, etc. Exam at doctors suggested possible gallbladder concern. After test results came back normal, doctor prescribed a course of Ibuprofen for 2 weeks. The pain was reduced but still continues and is now on both sides. At an unrelated follow up appointment (one scheduled prior to the start of the pain) the doctor believes my pain could be related to my myofascial pain syndrome/disorder. There was no known injury prior to the start of the pain.
About 24 hours after shot, experienced flu like symptoms-chills fever all over fatigue lasted 3-4 hours.  After these symptoms passed, massive headache for 3-4 hours.  The next morning, light headed upon standing and felt faint, then brain fog began tingling in feet/legs arm/hands and head.  This continues but now having pain in legs and arms and brain fog is increased 12 days going and getting more pain in legs more brain fog.  Contacted primary care on 04/12/2021 and had office visit 04/13/2021.
Patient states the next morning around 10 am felt tingling in her bottom lip and lip swelled.  Resolved on its own by around 1 pm. Did NOT take anything to help with symptoms.
She experienced severe itching/ continued itchy; Redness started looking bruised; arm felt warm to touch/ arm hot to touch; Arm sensitive; Redness from point of vaccination to elbow; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (She experienced severe itching/ continued itchy), CONTUSION (Redness started looking bruised), SKIN WARM (arm felt warm to touch/ arm hot to touch), SENSITIVE SKIN (Arm sensitive) and INJECTION SITE ERYTHEMA (Redness from point of vaccination to elbow) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In July 2021, the patient experienced INJECTION SITE PRURITUS (She experienced severe itching/ continued itchy), CONTUSION (Redness started looking bruised), SKIN WARM (arm felt warm to touch/ arm hot to touch), SENSITIVE SKIN (Arm sensitive) and INJECTION SITE ERYTHEMA (Redness from point of vaccination to elbow). In July 2021, INJECTION SITE PRURITUS (She experienced severe itching/ continued itchy), CONTUSION (Redness started looking bruised), SKIN WARM (arm felt warm to touch/ arm hot to touch), SENSITIVE SKIN (Arm sensitive) and INJECTION SITE ERYTHEMA (Redness from point of vaccination to elbow) had resolved.            No relevant concomitant medications were reported.   Treatment information was not provided.   This case was linked to MOD-2021-262510 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow up information included outcome of event (itching at injection site and redness at injection site) updated to recovered/resolved from unknown and new event (redness started looking bruised, arm hot to touch, arm sensitive) added. On 29-Jul-2021: Non significant Follow-up received.
heart pain consistent for about a week after 2nd dose and now the heart pain comes and goes with certain activity.; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A 29-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0170 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in left arm on 22Apr2021 (Batch/Lot Number: EW0170) as DOSE 1, SINGLE for covid-19 immunization). Medical history included coeliac disease, autoimmune disorder and gluten allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination patient has not been tested for COVID-19. On 23Apr2021 the patient experienced heart pain consistent for about a week after 2nd dose and now the heart pain comes and goes with certain activity. The adverse event resulted in emergency room/department or urgent care. The outcome of the event was not recovered.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
The day after the shot, I was hot and I was fatigued. Had skin and muscle burn with pool physical therapy, had nerve pain in foot and ankle. This all lasted for a few months all of this has subsided, except for slight nerve in foot and ankle.
Dizziness/vertigo began 4 hrs. after vaccine. Tired next day.  Second day, I had excruciating stabbing pain on my right browbone at sinus point, lasting approx. 18 hours.  The pain was debilitating, and I was fatigued. Still dizzy throughout that day.
About 24 hours after vaccination developed redness at injection site. No fever, no warmth, no induration, no lymphadenopathy.